The Effects of Cell Therapy on Seizures in Animal Models of Epilepsy: Protocol for Systematic Review and Meta-analysis of Preclinical Studies

Overview

Journal Syst Rev

Publisher Biomed Central

Date 2019 Nov 3

PMID 31675988

Citations 1

Authors

Naomi Dvir

Muhammad S Javaid

Nigel C Jones

Kim L Powell

Patrick Kwan

Terence J OBrien

Ana Antonic-Baker

Affiliations

Soon will be listed here.

Abstract

Background: Epilepsy is one of the most common and serious brain conditions, characterised by recurrent unprovoked seizures. It affects about 1% of the population worldwide. Despite a range of antiepileptic drugs being available, one third of the patients do not achieve adequate seizure control. Only a minority of these patients may be suitable to undergo surgical resection of the seizure focus, but this is an invasive and not always successful procedure. There is an urgent need to develop more effective treatment options for uncontrolled seizures. With the recent advances in regenerative and translational medicine, cell therapies could prove to be beneficial. Here we describe the protocol for a proposed systematic review and meta-analysis to assess the effects for cell transplantation in animal models of epilepsy.

Methods: We will include all preclinical animal models of epilepsy that evaluate the effects of cell transplantation compared to the untreated control. The primary outcome will be the change in frequency and duration of seizures from baseline measured by video electroencephalography (EEG). The secondary outcomes will include histological and neurobehavioural assessments. We will perform an electronic search of MEDLINE via PubMed, Web of Science, and EMBASE. Search results will be screened independently by two reviewers and confirmed by a third reviewer. Data from eligible studies will be extracted and pooled, and the summary estimate of effect size will be calculated using DerSimonian and Laird random effects meta-analysis. Heterogeneity will be explored using sub-group meta-analysis, and meta-regression risk of bias will be assessed by using the CAMARADES checklist for study quality tool.

Discussion: The purpose of this systematic review is to assess and summarise the existing literature in the field of cell transplantation as a treatment for epilepsy in animal models. Efficacy will be measured by evaluating the reduction in seizure intervals, number, and duration, within animal models of epilepsy. Analysis of the existing literature will mark the achievement made in the field and locate the existing gaps, a process that will aid in the search for the next needed step.

Systematic Review Registration: CRD42018103628.

Citing Articles

CXCR5 Regulates Neuronal Polarity Development and Migration in the Embryonic Stage via F-Actin Homeostasis and Results in Epilepsy-Related Behavior.

Zhang Z, Zhang H, Antonic-Baker A, Kwan P, Yan Y, Ma Y Neurosci Bull. 2023; 39(11):1605-1622.

PMID: 37460877 PMC: 10603003. DOI: 10.1007/s12264-023-01087-w.

References

Hunt R, Baraban S . Interneuron Transplantation as a Treatment for Epilepsy. Cold Spring Harb Perspect Med. 2015; 5(12). PMC: 4665034. DOI: 10.1101/cshperspect.a022376. View

Loscher W . Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs. Neurochem Res. 2017; 42(7):1873-1888. DOI: 10.1007/s11064-017-2222-z. View

McNamara J . Kindling model of epilepsy. Adv Neurol. 1986; 44:303-18. View

Bang O, Lee J, Lee P, Lee G . Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005; 57(6):874-82. DOI: 10.1002/ana.20501. View

Macleod M, OCollins T, Howells D, Donnan G . Pooling of animal experimental data reveals influence of study design and publication bias. Stroke. 2004; 35(5):1203-8. DOI: 10.1161/01.STR.0000125719.25853.20. View

Venkataramana N, Kumar S, Balaraju S, Radhakrishnan R, Bansal A, Dixit A . Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res. 2010; 155(2):62-70. DOI: 10.1016/j.trsl.2009.07.006. View

Sloviter R . Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 1987; 235(4784):73-6. DOI: 10.1126/science.2879352. View

Ngugi A, Bottomley C, Kleinschmidt I, Sander J, Newton C . Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010; 51(5):883-90. PMC: 3410521. DOI: 10.1111/j.1528-1167.2009.02481.x. View

Pitkanen A, Bolkvadze T, Immonen R . Anti-epileptogenesis in rodent post-traumatic epilepsy models. Neurosci Lett. 2011; 497(3):163-71. DOI: 10.1016/j.neulet.2011.02.033. View

10.

Steinberg G, Kondziolka D, Wechsler L, Lunsford L, Coburn M, Billigen J . Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study. Stroke. 2016; 47(7):1817-24. PMC: 5828512. DOI: 10.1161/STROKEAHA.116.012995. View

11.

Ben-Ari Y . Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 1985; 14(2):375-403. DOI: 10.1016/0306-4522(85)90299-4. View

12.

Antonic A, Sena E, Lees J, Wills T, Skeers P, Batchelor P . Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol. 2013; 11(12):e1001738. PMC: 3866091. DOI: 10.1371/journal.pbio.1001738. View

13.

Sena E, van der Worp H, Bath P, Howells D, Macleod M . Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol. 2010; 8(3):e1000344. PMC: 2846857. DOI: 10.1371/journal.pbio.1000344. View

14.

Sato M, Racine R, McIntyre D . Kindling: basic mechanisms and clinical validity. Electroencephalogr Clin Neurophysiol. 1990; 76(5):459-72. DOI: 10.1016/0013-4694(90)90099-6. View

15.

Goldberg E, Coulter D . Seizing the opportunity: stem cells take on epilepsy. Cell Stem Cell. 2014; 15(5):527-8. DOI: 10.1016/j.stem.2014.10.017. View

16.

Suarez-Monteagudo C, Hernandez-Ramirez P, Alvarez-Gonzalez L, Garcia-Maeso I, de la Cuetara-Bernal K, Castillo-Diaz L . Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor Neurol Neurosci. 2009; 27(3):151-61. DOI: 10.3233/RNN-2009-0483. View

17.

Shetty A, Hattiangady B . Concise review: prospects of stem cell therapy for temporal lobe epilepsy. Stem Cells. 2007; 25(10):2396-407. PMC: 3612506. DOI: 10.1634/stemcells.2007-0313. View

18.

Lee J, Hong J, Moon G, Lee P, Ahn Y, Bang O . A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells. 2010; 28(6):1099-106. DOI: 10.1002/stem.430. View

19.

Kwan P, Sills G, Brodie M . The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther. 2001; 90(1):21-34. DOI: 10.1016/s0163-7258(01)00122-x. View

20.

Sills G, Brodie M . Update on the mechanisms of action of antiepileptic drugs. Epileptic Disord. 2002; 3(4):165-72. View